Susquehanna International Group, LLP Vista Gen Therapeutics, Inc. Call Options Transaction History

Susquehanna International Group, LLP

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2022 Nov 14, 2022	BUY	$0.14 - $4.8 $8,162 - $279,840	58,300 Added 56.77%	161,000 $24,000
Q2 2022 Aug 15, 2022	BUY	$0.88 - $1.73 $79,992 - $157,257	90,900 Added 770.34%	102,700 $90,000
Q4 2021 Feb 14, 2022	SELL	$1.67 - $2.76 $10,521 - $17,388	-6,300 Reduced 34.81%	11,800 $23,000
Q3 2021 Nov 15, 2021	BUY	$2.62 - $3.45 $47,422 - $62,445	18,100 New	18,100 $50,000

2.7M

Ticker VTGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 206,836,000
Market Cap $623M
Description
VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III d...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.